Novel use of adenoviruses and nucleic acids coding therefor
WO2012022496A2
Method for killing tumor stem cells
MX2007008136A
Method for reversing multiple resistance in animal cells.
EP1689445A1
Novel use of adenoviruses and nucleic acids that code for said viruses
CA2590257A1
Novel adenoviruses, nucleic acids that code for the same and the use of said viruses
CN1705740A
Adenovirus expressing genes in reverse order and use thereof
KR20050061530A
Novel adenoviruses, nucleic acids coding therefor, and use thereof
US2006057113A1
Adenoviruses, nucleic acids coding therefor, and use thereof
CA2487811A1
Use of adenoviruses replicating in a yb-1 dependent manner for the treatment of tumors
US2007116670A1
Use of the adenoviral E2 late promoter
DE10223534A1
Use of viruses containing oncogenes for treating tumors, can replicate only in cells having YB-1 transcription factor in the nucleus, also new viral oncogene proteins
AU2002229679B2
Use of transcription factor YB-1 in adenoviral systems
DE10065504A1
Adenoviral nucleic acid useful for preventing or treating malignant or benign tumors, by inducing cell lysis, comprises a sequence for the YB-1 protein
DE19929569A1
Composition for treating malignant disease, comprising E1A-defective adenovirus that can replicate in presence of YB-1 protein
